Low-molecular-weight heparin and survival in patients with malignant disease.
Kakkar
Ajay K
AK
Centre for Surgical Sciences, Institute of Cancer, Barts and the London School of Medicine and Dentistry, London, EC1 UK. akkakkar@tri-london.ac.uk
D000925:Anticoagulants / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D015201:Meta-Analysis as Topic; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight